Verastem, Inc.

US$8.41As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VSTMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (5.61%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.46
PE TTM —
TSR TTM (11.01%)
Mkt cap US$1.060B
ROIC (114.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
27.94%
(49.13%)
Hold 1|12|1|2|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.14
0.15
0.15
0.17
17.88%
18.36%
23.03%
35.56%
Revenue$M
54.87
53.79
53.78
52.20
1.18%
(1.33%)
1.13%
(4.43%)
Peers (US$1.060B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.528
0.264
0.175
EBIT/Intx
2.502
0.635
0.586
Own earn%
(47.67)
24.82
22.81
Sh yield%
23.84
28.92
27.61
Owners
Insiders/Inst%
8.90
47.99
Short interest%
1.97
SBC / revenue%
0.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
15–23
$1 testx
—
Incr. ROIC%
9